Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 discloses the results of Optimum Communications' 2026 Annual Meeting of Stockholders held on June 10, 2026, including voting tallies for the election of nine directors (Patrick Drahi, David Drahi, Dexter Goei, Dennis Mathew, Mark Mullen, Dennis Okhuijsen, Susan Schnabel, Charles Stewart, and Raymond Svider) and ratification of KPMG LLP as independent auditor. The detailed vote counts for and against each proposal are provided, making this a clear shareholder_vote_results disclosure. Board composition and auditor ratification are material to investors' assessment of governance and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from AbCellera's Annual Meeting of Shareholders held on June 11, 2026. The filing reports voting outcomes for three proposals: (i) election of two Class III directors (John S. Montalbano and Stephen R. Quake), (ii) ratification of Ernst & Young LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. All three proposals were approved by shareholders, with detailed vote tallies provided for each. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Angi Inc. held its Annual Meeting of Stockholders on June 10, 2026, with shareholders voting on three proposals: election of three Class II directors (Sandra Buchanan, Thomas C. Pickett Jr., and Glenn H. Schiffman), approval of the amended and restated 2017 Stock Plan, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with disclosed vote tallies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
Stockholders voted at the Annual Meeting on four proposals: election of six directors, advisory vote on executive compensation, approval of the Third Amended and Restated Omnibus Incentive Plan (increasing share pool by 2.5 million shares and extending the plan to 2036), and ratification of Grant Thornton as independent auditor. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Arcus Biosciences' June 11, 2026 annual meeting, covering three proposals: election of Class II directors (Dietmar Berger, David Lacey, Nicole Lambert, and Johanna Mercier), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed vote tallies (votes for, against, withheld, abstentions, and broker non-votes) for each proposal, which is the standard format for Item 5.07 disclosures and constitutes material information about corporate governance outcomes.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-12
Item 5.02
The disclosure centers on Amendment No. 1 to Danny Rittman's employment agreement as CTO/CISO, which modifies his compensation through: (1) a base salary increase to $180,000 effective June 1, 2026; and (2) a grant of 1,000,000 performance-based stock options at $4.98/share with milestone-based vesting tied to technical deliverables (VisionRF data room, StratumAI agent release, cybersecurity framework, and EDA strategy room). While the title update is noted, the substantive disclosure is compensatory in nature—salary adjustment and equity grant—making this an exec_compensation event rather than appointment or departure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-12
Item 1.01
Sadot Group entered into a Written Option Agreement granting an exclusive, irrevocable six-month option to acquire 100% of membership interests in seven California-based real estate LLCs representing 147 residential units with a total agreed portfolio value of $125.5 million and equity value of $69.5 million.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-12
Item 3.02
The Company issued 132,803 shares of Common Stock (17.71% of outstanding shares) on June 6, 2026, as payment for an Option Fee under the Option Agreement, pursuant to Section 4(a)(2) of the Securities Act as an unregistered private placement to an accredited investor.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-12
Item 1.01
Splash Beverage Group invested $217,479.24 to acquire 2,000,000 common shares and 1,000,000 warrants of Avicanna Inc. in a private placement, representing a strategic capital allocation aligned with the Company's pivot into a cannabinoid-based platform.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
Michael Bondurant was appointed as Chief Operating Officer, effective June 8, 2026. The appointment also includes compensatory arrangements for Bondurant and Brady Cobb (base salary, performance bonuses, and stock option grants) and adoption of an RSU Plan.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-12
Item 5.02
Jason Pernell, President of Trulieve Cannabis Corp., terminated his employment effective immediately on June 11, 2026, pursuant to a mutual agreement and Separation Agreement. The disclosure centers on the departure of a named executive officer from a senior position, with associated severance arrangements including cash payment, COBRA continuation, and equity vesting. This is a material executive departure that would affect investor assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Opendoor's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for three proposals: election of three Class III directors (David Benson, Eric Feder, Eric Wu), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Clover Health's June 10, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies on three proposals: election of three Class II directors (Kouzoukas, Toy, and Tran), a non-binding advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities. Shareholder meeting outcomes are material to investors as they determine board composition and affirm key governance decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from LENZ Therapeutics' 2026 annual meeting held on June 12, 2026. The filing reports voting outcomes for two matters: (1) election of three Class II directors (Evert Schimmelpennink, Jeff George, and Shelley Thunen), and (2) ratification of Ernst & Young LLP as independent auditor. The tabulated vote counts for each nominee and proposal are the core content of Item 5.07, which is the standard Item for reporting annual meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 disclosure reports the results of Playtika's annual meeting of stockholders held on June 11, 2026, including voting outcomes for three proposals: election of six directors, ratification of the independent auditor (Kost Forer Gabbay & Kasierer), and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors' understanding of corporate governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Enovix's 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting outcomes for three proposals: election of eight directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals were approved by stockholders with detailed vote tallies (For, Against, Abstain, and Broker Non-Votes). This is a material disclosure as it documents shareholder approval of the board composition and executive compensation arrangements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-06-12
Item 1.01
NEONC Technologies entered into a Securities Purchase Agreement to issue up to $5,000,000 of Series A Convertible Preferred Stock in a private placement to accredited investors under Section 4(a)(2) and Regulation D Rule 506 exemptions. The 6,000 shares of Series A Preferred Stock carry conversion rights into common stock at 80% of the lowest closing price during the five trading days prior to conversion, subject to a beneficial ownership limitation of 4.99% (or 9.99% upon election), resulting in material dilution to existing common shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 2.03
The Company issued an unsecured promissory note of $191,475 to its sponsor to fund a trust account extension, creating a direct financial obligation with conditional forgiveness and conversion rights that affects the Company's capital structure and timeline for completing its initial business combination.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-12
Item 3.02
The Company issued an unregistered convertible note with underlying Units issuable upon conversion, subject to registration rights and transfer restrictions tied to the initial business combination, representing a dilutive issuance of equity securities.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Company extended its Business Combination Deadline from June 13, 2026 to July 13, 2026 for its merger with MicroTouch Technology Inc., a governance action that materially affects the transaction timeline and likelihood of consummation.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 5.03
Aeries Technology effected a 1-for-8 reverse share consolidation through an amendment to its Articles of Association, reducing outstanding Class A ordinary shares from approximately 45.9 million to 5.7 million. In connection with this capital structure change, the Company adjusted warrant terms by reducing the shares issuable per warrant to 1/8th and increasing the exercise price eight-fold to $92.00 per share.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-12
Item 5.02
The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-12
Item 1.01
Titan Acquisition Corp entered into a Business Combination Agreement with OpenPayd Global Holdings Limited and related parties on June 1, 2026, with a first amendment executed on June 11, 2026. This constitutes a material acquisition/change of control transaction typical of SPAC business combinations, disclosed under Item 1.01 (Entry into a Material Definitive Agreement). The amendment clarifies warrant redemption procedures, confirming the parties' commitment to completing the acquisition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Coupang's June 11, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: (1) election of seven directors, (2) ratification of Samil PricewaterhouseCoopers as independent auditor, and (3) advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Krispy Kreme's June 10, 2026 annual meeting. The filing presents detailed voting tallies for four proposals: election of eight directors, advisory approval of executive compensation, ratification of Grant Thornton LLP as auditor, and approval of the 2021 Omnibus Incentive Plan amendment. All proposals passed with substantial majorities, making this a material governance event that investors rely on to assess board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder voting results from Lineage's June 9, 2026 annual meeting of stockholders. The filing presents final vote tallies for three proposals: (i) election of all ten director nominees, (ii) ratification of PricewaterhouseCoopers LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. This is the quintessential Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a clear disclosure of shareholder vote results from Portillo's 2026 Annual Meeting of Shareholders held on June 9, 2026. The filing reports final voting tallies for three proposals: (i) election of seven directors, (ii) advisory approval of Named Executive Officer compensation, and (iii) ratification of Deloitte & Touche LLP as independent auditor. This is a textbook Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-12
Item 5.02
Rajeev Date's resignation as Lead Independent Director effective immediately is the principal disclosed action. While the filing also mentions Craig Broderick's appointment as the new Lead Independent Director, the core event centers on Date's departure after nearly 13 years of service, including his role as Lead Independent Director since November 2024. The departure of a long-tenured lead independent director is material to investors assessing board governance and continuity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-12
Item 1.01
Noble Finance II LLC, a wholly owned subsidiary of Noble Corporation plc, entered into an indenture on June 11, 2026, issuing $800 million in aggregate principal amount of 6.250% Senior Notes due 2034. This material capital structure event includes extensive covenants and events of default that materially restrict the company's operational and financial flexibility.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-06-12
The filing announces a general meeting of shareholders scheduled for 23 July 2026 to vote on a proposed $2.0 billion share repurchase programme previously approved by the Board on 7 May 2026. While this is technically a notice of a future shareholder vote rather than results of a completed vote, the disclosure of a material shareholder action (approval of a significant capital allocation program) is a governance event that would affect investor assessment. The $2.0bn repurchase is material to the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-12
EX-99.1
The exhibit discloses results of an Extraordinary General Meeting held on 11 June 2026, with shareholder approval of three resolutions: agenda approval, dividend payment of KZT 850 per share for 1Q 2026, and election of three members to the Counting commission. This is a classic shareholder vote result disclosure (Item 5.07 equivalent), material because it announces a dividend distribution and governance appointments approved by shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
The filing discloses entry into material definitive agreements on June 9, 2026: a Second Amended and Restated Trust Agreement and an Amended and Restated Sponsor Agreement. While Item 1.01 nominally covers M&A activity, these agreements fundamentally restructure the Trust's governance and compensation arrangements, particularly by authorizing staking programs and directing all staking rewards to the Sponsor outside the Trust's NAV. This is a material governance and economic restructuring affecting shareholder interests, but does not fit cleanly into the M&A taxonomy (no acquisition, merger, or disposition). The event is material to investors as it alters the economic terms and control structure of the ETF.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are material to investors as they affect share count, capital allocation, and potential accretion/dilution, this disclosure does not fit neatly into the more specific event categories (it is neither a dilutive issuance, executive compensation, nor M&A activity). The renewal of a repurchase authorization is a governance and capital allocation decision material to shareholders but best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are routine for closed-end funds seeking to manage discount-to-NAV dynamics, the renewal and authorization of a material repurchase capacity (5% of shares) would affect investor assessment of capital allocation and share price support. This does not fit neatly into the more specific event categories but represents a material corporate action disclosed under Item 8.01.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are routine for closed-end funds seeking to manage discount-to-NAV dynamics, the renewal and authorization of a material repurchase capacity (5% of shares) would be material to investors assessing capital allocation and potential accretion/dilution. This does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This Item 5.07 filing discloses the final voting results from MercadoLibre's Annual Meeting of Stockholders held on June 9, 2026. The section presents detailed vote tallies for three proposals: election of Class I directors (with individual vote counts for each nominee), advisory approval of named executive officer compensation, and ratification of the independent auditor (Pistrelli, Henry Martin y Asociados S.A.). All three proposals passed. This is a standard shareholder vote results disclosure that materially informs investors of governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of American Integrity Insurance Group's annual meeting of stockholders held on June 11, 2026. The filing presents voting results for four proposals: election of director Steven Smathers, ratification of Forvis Mazars as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. All proposals received sufficient votes for approval. This is material as it documents stockholder actions on governance and audit matters.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
The filing discloses the appointment of Collin Gallagher to the Board as a Class III director effective June 12, 2026, designated by Thoma Bravo pursuant to a Director Designation Agreement. While the section also mentions Nabil Hamade's resignation, the principal disclosed action centers on the appointment of a new director to fill the vacancy. Board composition changes are material to investors assessing corporate governance and control.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-12
Item 5.07
This 8-K Item 5.07 discloses the results of Medline Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on four matters: election of 12 directors, advisory approval of executive compensation, frequency of advisory compensation votes (approved for annual frequency), and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies for each director and each proposal are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-11
Item 1.01
W. R. Berkley Corporation entered into a First Amendment to its Credit Agreement on June 9, 2026, extending the maturity date of the revolving credit facility from April 1, 2027 to June 9, 2031, materially extending the company's liquidity runway and modifying its capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The disclosure centers on the Board's election of Judson Althoff to the Board of Directors, effective June 24, 2026. This is a clear appointment of a director to the registrant's board. While the section also mentions his participation in the standard independent director compensation program, the principal disclosed action is the appointment itself, not a compensatory arrangement unique to Mr. Althoff. Board composition changes are material to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 7.01
Service Corporation International announced an increase to its share repurchase program by approximately $472 million, bringing total authorization to $600 million. While share repurchase programs are material to investors as they signal management's confidence in valuation and affect capital allocation, this disclosure does not fit neatly into the standard taxonomy categories (it is neither a dilutive issuance, M&A activity, nor executive compensation). The announcement reflects a significant capital allocation decision that would affect a reasonable investor's assessment of the company's financial strategy and shareholder returns.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-11
Item 5.07
This is a clear disclosure of shareholder voting results from TJX's annual meeting held June 9, 2026, covering three proposals: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies (For, Against, Abstaining, Broker Non-Votes) for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-11
Item 8.01
This disclosure reports the completion of regulatory approvals and stockholder approval for a merger transaction between Arrow Financial Corporation and Adirondack Bancorp, Inc., with closing anticipated on July 1, 2026. The filing documents the material acquisition activity, including approval from the New York State Department of Financial Services, the Office of the Comptroller of the Currency, and Adirondack stockholders on June 9, 2026, representing a significant change of control event that would materially affect a reasonable investor's assessment of Arrow.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-11
Item 5.02
The filing discloses both the retirement of Russell R. Shaller as President and CEO and the appointment of Vineet Nargolwala as President and CEO, effective June 8, 2026. While both events are disclosed, the principal action emphasized is Nargolwala's appointment to the top executive role, supported by detailed compensation terms ($1M base salary, $6.4M annual stock award, severance provisions, and change-of-control protections). The appointment of a new CEO is material to investors and represents the primary disclosed event, though the departure of the prior CEO is also significant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Matthew Bradford White as Chief Legal Officer effective June 8, 2026. While the section also details compensatory arrangements (base salary of $500,000, performance bonus, RSUs, signing bonus, and retention bonus), the principal disclosed action is the appointment of a named executive officer to a material position. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-11
Item 2.02
Adobe issued a press release on June 11, 2026 announcing financial results for Q2 fiscal year 2026 ended May 29, 2026, disclosing both GAAP and non-GAAP financial measures including revenue growth, operating income, net income, diluted EPS, operating margin, and tax rate.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
Steven Day was appointed as interim Chief Financial Officer of Adobe effective immediately, following the resignation of Daniel Durn as CFO effective June 15, 2026. Day has been with the company since 2006 and brings substantial prior experience in financial leadership roles.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-11
Item 5.02
The Board appointed John C. Fortson as Executive Vice President & Chief Financial Officer, effective July 20, 2026, with a base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards. This represents a material change in senior leadership responsible for financial management and reporting.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-11
Item 7.01
WSFS entered into a partnership with Elan Financial Services to issue WSFS-branded credit cards and agreed to sell its credit card portfolio ($36.3 million outstanding balance) to Elan. While characterized as a partnership, the core transaction involves a material disposition of a business line (credit card portfolio) with anticipated financial impacts of ~$1.7 million gain and ~$1.3 million provision release in Q2 2026. This constitutes a material disposition activity reportable under Item 1.02 or 2.01 framework, though disclosed under Item 7.01.
View raw filing on EDGAR →